SpineOvations Gathers IP To Address Spinal Disc Repair; Trial Planned
This article was originally published in The Gray Sheet
Seeing new possibilities for noninvasive treatment of back pain, San Diego start-up SpineOvations is gathering intellectual property and expects to launch an international trial of its DiscSeal injectable agent for repairing spinal disc tears in 2008
You may also be interested in...
Ipsen’s business strategy calls for accessing external innovation across its pipeline, combined with geographic expansion, realizing the unmet potential of its marketed products and business efficiencies in manufacturing and operations.
The proposal, which would increase capacity for pandemic supplies, is similar to ideas President Trump embraced pre-pandemic.
Sanofi has named the head of its new API business; Sweden's Enzymatica has hired talent from J&J and L'Oreal; and Bayer has a new transformation officer.